Drugs / CX501
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00987142 | Dec 2006 → May 2010 | epidermolysis bullosa | Tigenix S.A.U. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CX501 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00987142 ↗ |